Good afternoon, and thank you for joining us for BioLife Solutions, Inc.'s fourth quarter and full year 2025 conference call.

BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

BioLife Plasma, a plasma donation center, opened its 200th U.S. location and first location in Pearland on March 25. The new plasma service center located at 3020 Kirby Drive is part of the ...

BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...

On May 27, H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at $30. The bullish sentiment comes after the firm adjusted its ...

The MarketWatch News Department was not involved in the creation of this content. Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth ...

BioLife CEO Bill Jones calls for a new global health vocabulary, shifting from weight-loss language to biology-driven terms that support metabolic well-being, body positivity, and regenerative care.

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces ...

BioLife Solutions (BLFS-2.70%) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 ...

On the wall of Biolife's new offices are articles spanning much of the last decade from a variety of local newspapers, including this one. Every few years, a large, blaring story announces that the ...

Image source: The Motley Fool. BioLife Solutions (NASDAQ:BLFS) concluded a year of substantial revenue and margin expansion, with the business reset around core consumables and leadership in the ...